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Occupational accidents, predominantly those encompassing cutting and piercing instruments 
among healthcare workers, have been a cause of growing concern. This is partly because 
of the prevalence of diseases and infections caused by the human immunodeficiency virus 
(HIV), hepatitis B virus and hepatitis C virus (Tonarelli, 2016). Sharps injuries are one of 
the leading categories of accident sustained by healthcare workers and have been described 
as an important public health concern (Pathak et al, 2012).
The Centers for Disease Control and Prevention (2008) defines sharps injuries as ‘skin-
penetrating stab wounds caused by a sharp instrument and accidents in a medical setting’. 
Sharps injuries have also been described as lacerations or puncture wounds (Health and 
Safety Executive, 1995), piercings of the skin (Hersey and Martin, 1994), and cuts and 
pricks (Royal College of Nursing, 2013). Within medical and nursing literature they are also 
defined as a percutaneous injury (Health and Safety Executive, 2016). Similarly, definitions 
of sharps themselves within healthcare are also wide and varied, but can include needles 
(Muralidhar et al, 2010); razors, broken glass and scissors (Royal College of Nurses, 2013); 
lancets and scalpels (World Health Organization, 2003).
The Eye of the Needle report (Public Health England, 2014) highlighted that between 
2004 and 2013 there were 4830 occupational exposures to blood or other high-risk body 
fluids in the UK. Of these exposures, 3396 were because of a sharps injury. Nurses and 
healthcare assistants accounted for 42% of all reports, while doctors and dental professionals 
comprised 41% and 5% of reports respectively. Ancillary healthcare workers, who typically 
have no direct patient contact, were also injured by incorrect disposal of sharps (Public 
Health England, 2014).
There are various psychological effects that can occur following serious sharps injuries 
among healthcare workers. Some of these effects can be severe, including post-traumatic 
stress disorder (Naghavi et al, 2013), anxiety (NHS Employers, 2013), depression (McDowell, 
2012), insomnia, loss of appetite, sleeplessness and crying (Gershon et al, 2000).
Legislation introduced in the UK since the 1974 Health and Safety at Work Act, 
supplemented by European Union Directives, World Health Organization-approved 
publications and other guidelines, have consistently highlighted the responsibilities of 
employers and employees in relation to safe working environments and the safe use of 
sharps within healthcare (World Health Organization, 2003; European Agency for Safety 
and Health at Work, 2018). Yet evidence suggests that there are still health and safety 
breaches regarding sharps within many healthcare settings and non-compliance with sharps 
regulations (Health and Safety Executive, 2015; 2016).
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Research into sharps injuries has focused on the volume of incidents and, to a 
smaller degree, the psychological impact of those incidents. This narrative literature 
review instead explored the financial cost of sharps injuries as reported by both UK 
and international studies. This involved a search of 13 electronic databases and 
grey literature, with no set date limits, in June 2019. Both direct and indirect costs of 
sharps injuries were identified, indicating the high financial costs of such incidents 
to healthcare systems across many different countries each year. Further research is 
urgently needed to address the continued prevalence of sharps injuries and to reduce the 
associated costs.
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These aspects of sharps injuries have been explored within the literature, yet an under-
researched consequence of sharps injuries is the financial cost. To explore this topic, the 
researchers conducted narrative literature review to explore the financial cost of sharps 
injuries internationally.
Method
A narrative literature review was conducted by searching the following electronic 
databases: AMED, BMJ Journals collection, CINAHL Plus with Full Text (EBSCO), 
Clinical Evidence, Cochrane Library (Wiley), Internurse, Medline (EBSCO), NICE 
Evidence, PubMed, PubMed Central, PsycArticles, PsycINFO, and ScienceDirect. 
Finally, Google Scholar was targeted to search for grey literature. This was done to ensure 
that all relevant published papers on the topic area were covered to make the review as 
comprehensive as possible.
The search was limited to papers published in English and articles without an accessible 
abstract or full text were excluded. To ensure that a full view of the cost of sharps injuries 
over time was achieved, there was no time limit set.
The process for the literature review followed four stages:
 ■ Search terms were used to search relevant databases
 ■ Titles and abstracts were screened from the results of the search and those deemed 
relevant were saved as a file
 ■ The full texts of the relevant articles were retrieved, read and relevant data extracted. 
Additional relevant papers were identified from bibliographies
 ■ The extracted data were then scrutinised and grouped into relevant categories, such as 
direct and indirect costs, monetary costs and reports from individual countries.
Search terms included the following key words: cost, money, financial, sharps, needlestick, 
injury, inoculation, percutaneous, nurse, healthcare worker, policy, guideline, seroconversion. 
These keywords were used in combination to narrow the searches, while the Boolean 
operator ‘AND’ was used to expand the search.
Results
The literature review identified the direct and indirect costs, as well as the overall 
annual costs, of sharps injuries as reported by studies from 11 countries. These countries 
were the USA, Russia, Spain, France, Sweden, Chile, Belgium, South Korea, Italy, 
Germany and the UK.
Direct and indirect costs
The Centers for Disease Control and Prevention (2008) defined the direct costs of a sharps 
injury involving a needle as including baseline and follow-up laboratory testing for the 
injured person; provision of post-exposure prophylaxis and any potential side effects; 
and compensation for the affected individual/s. Indirect costs related to: time and wages 
diverted to receiving or providing exposure-related care; lost productivity associated 
with reporting and receiving initial and follow-up treatment; healthcare provider time to 
evaluate and treat an individual; healthcare provider time to evaluate and test the source 
of the incident; and staff absence. Additional indirect costs could also include disability 
of the affected individual (Sharma et al, 2010) and the potential economic impact on the 
individual (Trueman et al, 2008).
Lee (2005) investigated the human and psychological effects of sharps injury involving 
needles in a study of 110 US nurses. In total, 77 working days were missed, 10 of which 
were from seeking and receiving medical attention, while six were because of the side 
effects of precautionary HIV prophylaxis treatment. However, the majority (61) of days 
were lost because of the emotional distress and anxiety created by the injury. Similarly, 
a study of nurses in 13 European countries and Russia (n=634) showed that, following a 
sharps injury involving needles, 12.3% changed their working habits or department and 
2.4% stopped working completely (Costigliola et al, 2012).
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Total costs per year
Mannocci et al (2016) conducted a systematic review to explore the cost of an individual 
sharps injury; this study appears to give the most up-to-date data. A total of 14 relevant 
studies were identified from eight countries across the world, namely the USA, Spain, 
France, Sweden, Chile, Belgium, Korea and Italy. Using modelling and data divulged 
from individual studies, the aggregate direct and indirect cost of one sharps injury was 
calculated as being between $650 and $750. However, this figure did not take litigation 
or compensation into account, so the actual figure is likely to be even higher than this.
Various figures have been attributed to the cost of sharps injury across different countries. 
In the USA, O’Malley et al (2007) analysed the cost of managing occupational exposures to 
infected blood and body fluids, a main cause of which is sharps injuries, in four healthcare 
facilities. The mean cost following staff exposure to HIV infected patients was $2456, 
while the management of staff exposed to patients infected with hepatitis C cost $650 on 
average. Exposure to patients with an unknown or non-infectious condition cost $376 on 
average. The range of costs was large, being calculated at $71 to $4838 per case. Similarly, 
Leigh et al (2007) investigated the cost of sharps injuries involving needles in the USA 
and found the mean average cost to be $596 ($339 direct medical costs and $257 lost work 
productivity costs).
Solano et al (2005) conducted a cost analysis of hepatitis B, hepatitis C and HIV 
follow-ups for healthcare workers who were accidentally exposed to blood and body 
fluids in Spain. The cost was calculated at €1502 for incidents involving a source that 
was positive for hepatitis C and HIV, and €172 for instances of source that was negative 
for all three viruses. In cases of hepatitis B, the mean cost was €388, with the main cost 
of the follow-up being serological tests and the provision of post-exposure prophylaxis. 
Meanwhile, Wittmann et al (2007) found the cost of a sharps injury involving needles in 
Germany to be €490, while Trueman et al (2008) investigated the cost of sharps injuries 
involving insulin needles in the UK and found the direct cost to be £362 per injury. In 
Sweden, Glenngård and Persson (2009) found the direct costs of sharps injuries to be €272 
per injury. Hanmore et al (2013) estimated the direct cost of sharps injuries in Belgium to 
be between €210 and €950 and the indirect costs to be between €63 and €844 per injury.
In South Korea, Oh et al (2008) analysed the costs of sharps injuries among healthcare 
workers by exploring data produced by 34 hospitals. These costs included pharmacy ($129), 
laboratory tests ($70), medical services ($28) and medical treatment ($10). The mean cost 
of each sharps injury was estimated to be $125 on average.
The total cost of sharps injuries per year have been estimated within certain countries 
worldwide. Leigh et al (2007) found that the cost of sharps injuries involving needles in 
the USA was $188.5 million per year. Meanwhile, Trueman et al (2008) found the total 
cost of sharps injuries involving insulin needles alone to be approximately £600,000 to 
the NHS. Meanwhile the Royal College of Nurses (2008) estimated that the annual cost 
of sharps injuries involving needles to the NHS to be £500 000 per trust. In France, the 
estimated annual costs of testing and treatment for sharps injuries involving needles was 
estimated to be $6.1 million (Saia et al, 2010), while Glenngård and Persson (2009) found 
the total cost to be €1.8 million per year in Sweden. In South Korea, Oh et al (2008) 
estimated the cost to be $884 385 per year based upon an estimation of 7057 sharps injuries 
occurring nationwide.
Many countries worldwide have reported the financial costs of sharps injuries. However, 
because of differences in population sizes, diverse healthcare settings, and various legislations 
and policies within these countries, it is difficult to make direct comparisons regarding the 
cost per injury or annually.
Conclusions
The overall costs of sharps injuries are difficult to enumerate because of the emotional 
effects, such as fear and anxiety from worrying about the potential consequences of an 
exposure. Whereas previous research has been conducted into these human costs, this 
review investigated and provided a synthesis of the financial costs of sharps injuries. 
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However, even in terms of the financial impact alone, there are both direct and indirect 
costs to consider, including those associated with drug toxicities, time absent from work, 
and the societal cost associated with an HIV, hepatitis B or hepatitis C seroconversion. The 
possible loss of a worker’s services in patient care following an injury, the cost of medical 
care and the charge for any litigation must also be considered. Taking this into account, it 
seems that the financial cost of sharps injuries within the UK and worldwide is large and 
potentially underestimated. These findings only make further research into the reasons why 
sharps injuries continue to occur, especially in the next generation of nurses, even more 
urgent in order to reduce these human and financial costs.
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Key points
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 ■ A review of literature from 11 countries found that sharps injuries led to large direct 
and indirect costs, including missed work days and the provision of precautionary 
treatment.
 ■ Further research into why sharps injuries continue to occur and how to prevent them 
is urgently needed from both a human and financial perspective.
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